Saint Luke's Newsroom

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Medicine eased symptoms of a condition that can cause fatigue and shortness of breath.

Grace Hoffman, Nutritional Coordinator with Saint Luke's Mid America Heart Institute and the Food As Medicine Everyday (FAME) program, shares healthy lunch options for kids and adults as school kicks off with the FOX4 morning show.

The Kansas City Star talked to Dr. Kayla Donnawell about the signs of heat-related illness and what parents can do for their children in excessive heat.

KSHB talked to an athletic trainer at Rockhill Orthopaedic Specialists about the warning signs of heat-related illness.

The program honors current or former chief information officers who have a proven track record of successful technology leadership, made significant contributions to the Kansas City technology and business community and inspired others through their personal, professional and civic contributions.

A new pilot program is training high school students to become nursing assistants at Saint Luke's East Hospital.

Hedrick Medical Center is one of only two critical access hospitals in Missouri to receive a five-star rating from the Centers for Medicare and Medicaid Services (CMS).